Gary Shapiro

Gary Shapiro

Company: Affini-T Therapeutics

Job title: Vice President - Discovery Biology

Seminars:

Expert Panel: Navigating the Complexities of Cell Therapy Engineering & Clinical Approval 9:00 am

A panel discussion covering a top-level overview of the latest advancements in cell therapy engineering Highlighting the need for “next generation” constructs and the opportunities they provide for patients Considering the broad challenges facing bioengineering of complex cell therapies to unveil the routes to overcoming theseRead more

day: Conference Day One

Addressing Gene Editing & Modifications to Enable More Complex Cell Therapies 3:30 pm

Leveraging CRISPR knock-in gene editing to increase sensitivity, potency, and safety of transgenic TCR-expressing T-cell therapies Harnessing armoring strategies to induce a coordinated immune response that resists exhaustion and allows for durable functional persistence of the engineered T-cellsRead more

day: Conference Day One

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.